2024 Presentations

Last August, the FDA announced that it was granting the pharmaceutical supply chain a one-year reprieve on complying with DSCSA. The expectation is that the additional time would allow the industry to invest and test this new electronic interoperable system for tracing drugs through the supply chain. This session will highlight how one chain is working through the process to comply with the law and they will share what they have learned and what is left to accomplish.

This session provided an analysis of the most up-to-date industry data and highlight pharmacy trends, issues, and forecasts in demographic sales and markets for 2024 and beyond

Pharmacies are increasingly gaining rightful traction as key drivers of improved outcomes, access, and equity. Join us for a presentation on the evolving value-based care landscape, including opportunities for pharmacies to engage and align with the strategy and vision set by value-based care leaders.

With patient access and pharmacy viability at stake, NACDS aligns policy, advocacy, and communications to advance priority issues at the federal and state levels. Dive deeper on the state of NACDS’ aggressive push for PBM reform, reimbursement, scope of practice, and health and wellness innovation in 2024.

Anxiety – financial, technological, political and health-related — have shoppers shifting their priorities for 2024 and beyond. Wendy Liebmann will share WSL Strategic Retail’s latest shopper and retail insights that reveal both opportunities and road blocks for the coming 18 months.

Discover the potential, challenges, and ethical considerations surrounding the application of AI in shaping the future of retail and healthcare.